MeiraGTx Holdings plc Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
MeiraGTx Holdings plc (MGTX) had Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments of $34.30 thousand as of 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments · last filed 2019-03-26
- 2018-12-31: Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments $34.30K.
| Period end | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments |
|---|---|
| 2018-12-31 | $34.30K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |